Developing Isoxazole as a Native Photo-Cross-Linker for Photoaffinity Labeling and Chemoproteomics

Angew Chem Int Ed Engl. 2022 Nov 21;61(47):e202209947. doi: 10.1002/anie.202209947. Epub 2022 Oct 19.

Abstract

Photoaffinity labeling is a powerful technique to interrogate drug-protein interactions in native cellular environments. Photo-cross-linkers are instrumental for this technique. However, the introduction of unnatural photo-cross-linkers may significantly reduce the bioactivity of the drug, thus impairing the chemoproteomic outcomes. Herein, we developed a common pharmacophore, isoxazole, into a natively embedded photo-cross-linker for chemoproteomics, which minimally perturbs the drug structure. The photo-cross-linking reactions of the isoxazole were thoroughly investigated for the first time. Functionalized isoxazoles were then designed and applied to protein labeling, demonstrating the superior photo-cross-linking efficiency. Subsequently, two isoxazole-based drugs, Danazol and Luminespib, were employed in chemoproteomic studies, revealing their potential cellular targets. These results provide valuable strategies for future chemoproteomic study and drug development.

Keywords: Chemoproteomics; Drug Discovery; Isoxazole; Photo-Cross-Linker; Photoaffinity Labeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Linking Reagents / chemistry
  • Isoxazoles
  • Photoaffinity Labels* / chemistry
  • Proteins* / chemistry

Substances

  • Photoaffinity Labels
  • Proteins
  • Isoxazoles
  • Cross-Linking Reagents